Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionRafferty Asset Management, LLC
Latest Disclosed Ownership44,842 shares
Latest Disclosed Value $ 3,590,947
Rafferty Asset Management, LLC reports 28.23% decrease in ownership of EW / Edwards Lifesciences Corporation

On May 15, 2026 - Rafferty Asset Management, LLC filed a 13F-HR form disclosing ownership of 44,842 shares of Edwards Lifesciences Corporation (MX:EW) valued at $3,590,947 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 62,479 shares of Edwards Lifesciences Corporation. This represents a change in shares of -28.23% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 44,842 -17,637 -28.23 3,591 -32.59 0.0146
2026-02-13 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 62,479 -2,694 -4.13 5,326 5.09 0.0184
2025-11-12 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 65,173 3,163 5.10 5,069 4.52 0.0164
2025-08-14 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 62,010 7,399 13.55 4,850 22.51 0.0160
2025-05-14 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 54,611 -12,276 -18.35 3,958 -20.06 0.0169
2025-02-14 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 66,887 5,788 9.47 4,952 22.82 0.0175
2024-11-13 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 61,099 -4,434 -6.77 4,032 -33.40 0.0138
2024-08-13 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 65,533 2,940 4.70 6,053 1.20 0.0225
2024-05-13 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 62,593 849 1.38 5,981 27.07 0.0223
2024-02-13 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 61,744 -1,685 -2.66 4,708 7.12 0.0199
2023-11-13 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 63,429 4,785 8.16 4,394 -20.56 0.0258
2023-08-11 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 58,644 3,330 6.02 5,532 20.87 0.0312
2023-05-11 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 55,314 2,131 4.01 4,576 15.35 0.0310
2023-02-13 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 53,183 20,054 60.53 3,968 44.94 0.0332
2022-11-14 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 33,129 18,044 119.62 2,737 90.86 0.0291
2022-08-12 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 15,085 -3,998 -20.95 1,434 -36.15 0.0132
2022-05-13 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 19,083 -1,901 -9.06 2,246 -17.37 0.0133
2022-02-10 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 20,984 1,110 5.59 2,718 20.80 0.0143
2021-11-10 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 19,874 6,076 44.04 2,250 57.45 0.0154
2021-08-10 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 13,798 908 7.04 1,429 32.56 0.0090
2021-05-10 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 12,890 962 8.07 1,078 -0.92 0.0074
2021-02-10 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,928 -30,655 -71.99 1,088 -67.99 0.0106
2020-11-13 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 42,583 -10,281 -19.45 3,399 -6.95 0.0411
2020-08-07 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 52,864 33,509 173.13 3,653 0.05 0.0515
2020-05-15 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 19,355 13,724 243.72 3,651 177.85 0.1528
2020-02-10 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 5,631 5,631 1,314 0.0202
2018-02-14 2017-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 0 -6,746 -100.00 0 -100.00
2017-11-13 2017-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 6,746 6,746 737 0.0165
2017-08-11 2017-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 0 -9,523 -100.00 0 -100.00
2017-05-11 2017-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 9,523 9,523 896 0.0197
2017-02-13 2016-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 0 -5,391 -100.00 0 -100.00
2016-11-14 2016-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 5,391 -465 -7.94 650 11.30 0.0237
2016-08-09 2016-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 5,856 -11,878 -66.98 584 -62.66 0.0395
2016-05-12 2016-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 17,734 17,734 0.00 1,564 0.0850
2014-11-14 2014-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 0 -3,300 -100.00 0 -100.00
2014-08-13 2014-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,300 3,300 283 0.0544
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.